Fiduciary Alliance LLC Cuts Stock Position in CME Group Inc. $CME

Fiduciary Alliance LLC lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 0.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,783 shares of the financial services provider’s stock after selling 73 shares during the quarter. Fiduciary Alliance LLC’s holdings in CME Group were worth $6,555,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Wayfinding Financial LLC acquired a new position in shares of CME Group during the first quarter worth $25,000. Webster Bank N. A. grew its stake in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares during the last quarter. Cornerstone Planning Group LLC increased its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC raised its stake in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the last quarter. Finally, Ransom Advisory Ltd acquired a new stake in CME Group in the first quarter worth about $31,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CME shares. Citigroup upped their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a “neutral” rating in a report on Thursday, July 3rd. UBS Group dropped their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research report on Monday, September 8th. Erste Group Bank lowered shares of CME Group from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 24th. Oppenheimer lifted their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research note on Thursday, July 24th. Finally, Barclays set a $298.00 target price on CME Group and gave the company an “equal weight” rating in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $260.60.

Insider Buying and Selling

In related news, Director William R. Shepard acquired 256 shares of the firm’s stock in a transaction on Wednesday, June 25th. The shares were acquired at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the acquisition, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ:CME opened at $258.83 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79. The stock’s 50-day moving average price is $273.13 and its 200-day moving average price is $270.62. The stock has a market capitalization of $93.28 billion, a PE ratio of 25.06, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the business posted $2.56 earnings per share. CME Group’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.